MedPath

Effect of early adminestration of corton in sepsis

Phase 3
Recruiting
Conditions
sepsis.
Systemic Inflammatory Response Syndrome of infectious origin with organ failureSevere sepsis
R65.1
Registration Number
IRCT20230701058635N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Age of 18–89 years
Systolic blood pressure of <90 mmHg or plasma lactate level of >2 mmol/L
SOFA score of =2 points consequent to the infection

Exclusion Criteria

Rejection of sepsis diagnosis after initial evaluations
Decision to limit or withdraw treatment
Steroid use within 4 weeks
Chemotherapy for underlying malignancy within 4 weeks
Etomidate use during hospitalization
Pregnancy or lactation
Informed written consent cannot be obtained from a patient or legal representative
Corticosteroides contraindications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to enter the septic shock. Timepoint: Every 1-hour. Method of measurement: According mean artrial pressure.
Secondary Outcome Measures
NameTimeMethod
Vasopressor requirement. Timepoint: Every 1-hour. Method of measurement: Starting a vasopressor drug (type and dose).;Need for mechanical ventilation support. Timepoint: Every 1-hour. Method of measurement: Patient intubation.;7-day mortality. Timepoint: 7 days after initial treatment. Method of measurement: patient follow-up.;28-day mortality. Timepoint: 28 days after initial treatment. Method of measurement: patient follow-up.;Length of stay in ICU. Timepoint: Daily. Method of measurement: patient follow-up.
© Copyright 2025. All Rights Reserved by MedPath